American Journal of Pharmacological Sciences
ISSN (Print): 2327-6711 ISSN (Online): 2327-672X Website: https://www.sciepub.com/journal/ajps Editor-in-chief: Srinivas NAMMI
Open Access
Journal Browser
Go
American Journal of Pharmacological Sciences. 2024, 12(3), 34-39
DOI: 10.12691/ajps-12-3-2
Open AccessArticle

Effects of Aqueous Extracts of Xylopia aethiopica (Annonaceae), Aframomum melegueta (Zingiberaceae), Picralima nitida (Apocynaceae) and Irvingia gabonensis (Irvingiaceae) on Glycaemia in Mice

Inès Christelle Assemian1, , Éric Kévin Bolou2, Don Josette Agre3 and Fafadzi Charlotte Ehon1

1Biotechnology, Agriculture and Valuation of Biological Resources Laboratory, Department of Biosciences, Félix Houphouët-Boigny University, Abidjan, Côte d’Ivoire

2National Floristic Center, Department of Biosciences, Félix Houphouët-Boigny University, Abidjan, Côte d’Ivoire

3Biology and Health Laboratory, Department of Biosciences, Félix Houphouët-Boigny University, Abidjan, Côte d’Ivoire

Pub. Date: September 03, 2024

Cite this paper:
Inès Christelle Assemian, Éric Kévin Bolou, Don Josette Agre and Fafadzi Charlotte Ehon. Effects of Aqueous Extracts of Xylopia aethiopica (Annonaceae), Aframomum melegueta (Zingiberaceae), Picralima nitida (Apocynaceae) and Irvingia gabonensis (Irvingiaceae) on Glycaemia in Mice. American Journal of Pharmacological Sciences. 2024; 12(3):34-39. doi: 10.12691/ajps-12-3-2

Abstract

The aim of this study was to evaluate the effects of aqueous extracts of Xylopia aethiopica (Annonaceae), Aframomum melegueta (Zingiberaceae), Picralima nitida (Apocynaceae) and Irvingia gabonensis (Irvingiaceae), designated AEXa; AEAm; AEPn and AEIg, respectively, on glycaemia in mice in order to contribute to the valorisation of their use in traditional medicine. In acute toxicity study: a total of 36 male mice (20-30g) were divided into 12 batches of 3 mice each, with three batches per extract. The animals in the control batch (batch 1) received distilled water, while those in batches 2 and 3 received 2000 and 5000 mg/kg body weight of all the four extracts via oral gavage for 14 days. In glucose tolerance test, 18 male mice (20-30g) were divided into 6 batches of 3 mice namely control and tested group which received an oral dose of aqueous extracts and glibenclamide at doses of 1 ml/100 g body weight (bw) and 2.5mg/100g body weight (bw) respectively for 125 minutes. Phytochemical screening was performed using chemical reactivity. Qualitative phytochemical tests carried out on all the aqueous extracts revealed the presence of numerous secondary metabolites, including polyterpenes, polyphenols, alkaloids, quinone compounds and saponins. Acute toxicity studies showed that these extracts were not toxic at doses of 2000 mg/kg and 5000 mg/kg body weight, nor did they cause any significant variation in the weight of the treated animals. AEPn and AEAm extracts significantly reduced the hyperglycaemia induced by the glucose solution, with an effect comparable to that of the standard antidiabetic drug glibenclamide. However, AEXa and AEIg had no significant effect on blood glucose levels in mice. The Results showed that A. melegueta and P. nitida had a great therapeutic potential and justify the use of these two plants in traditional medicine, particularly in the treatment of diabetes.

Keywords:
Aqueous extracts antihyperglycemic effect medicinal plants diabetes toxicity study

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Saggar S, Mir PA, Kumar N, Chawla A, Uppal J, Kaur A, Traditional and herbal medicines: opportunities and challenges. Pharmacognosy Research. 2022; 14.
 
[2]  Manda P, Manda O, Manda MV, Kroa E, Dano SD, Study of the acute and sub-acute toxicity of the natural remedy used in the treatment of malaria. Revue Ivoirienne Des Sciences et Technologie. 2017; 29: 145–458.
 
[3]  Lisy K, Campbell JM, Tufanaru C, Moola S, Lockwood C, The prevalence of disability among people with cancer, cardiovascular disease, chronic respiratory disease and/or diabetes: a systematic review. JBI Evidence Implementation. 2018; 16: 154–166.
 
[4]  Esser N, Utzschneider KM, Kahn SE, Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia. Diabetologia. 2020; 63.
 
[5]  Kroa E, Doh SK, Soko YN, Yohou KS, Koulaï O, Gbogbo M, N’Guessan K, Aka J, Kouassi D, Effect of the aqueous extract of Anthocleista djalonensis A. Chev (Gentianaceae) stem bark on the glycaemia of rabbits. 2016; 552-558.
 
[6]  Konkon NG, Ouatara D, Kpan WB, Kouakou TH. Medicinal plants used for treatment of diabetes by traditional practitioners in the markets of Abidjan district in Côte d’Ivoire. J Med Plants Stud. 2017; 5: 39–48.
 
[7]  Fleurentin J, Ethnopharmacology in the service of therapeutics:sources and methods. Hegel. 2012; 2: 12–18.
 
[8]  Adjoumani PE, Mea A, Gohi PKB, Bi JSI, Koffi JN, Kouakou JCA, Adjoumani PE, Mea A, Gohi PKB, Bi JSI, Koffi JN, Kouakou JCA, Effect of Picralina nitida on the glycemia and intestinal absorption of glucose in rat. GSC Biological and Pharmaceutical Sciences 2018; 5.
 
[9]  OCDE, Essai n° 425: Acute oral toxicity: dose adjustment method. OECD; 2022.
 
[10]  Shakya AK. Medicinal plants: Future source of new drugs,International Journal of Herbal Medicine. 2016; 4: 59–64.
 
[11]  N’Guessan K, Kadja B, Zirihi G, Traoré D, Aké Assi L, Phytochemical screening of some Ivorian medicinal plants usedin Krobou country (Agboville, Côte-d’Ivoire). Sciences & Nature. 2009; 6.
 
[12]  Juliette K, Désiré GV, Pierre OOJ, Théophile E, Marie E-LG, Didier DS, Anti-inflammatory activity of the combination of aqueous extracts of the bark of Musanga cecropioides (cecropiaceae) and fruits of Picralima nitida (apocynaceae). World Journal of Pharmaceutical Research. 2021; 10: 135-146.
 
[13]  Niang L, Gueye FK, Thioye A, Don OR, Diallo EHC, Soumare M, Ayessou NC, Ali MS, Cisse M, Diop CM, Hypoglycemic effect of acetonic and methanolic extracts from leaves and bark of Sclerocarya birrea (A. Rich.) Hochst in guinea pigs. International Journal of Innovation and Scientific Research. 2022; 61:34-42.
 
[14]  Tan MH, Johns D, Strand J, Halse J, Madsbad S, Eriksson JW, Clausen J, Konkoy CS, Herz M, for the GLAC Study Group, Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes. Diabetic Medicine. 2004; 21: 859–866.
 
[15]  Scheen AJ, Cardiovascular safety of DPP-4 inhibitors compared with sulphonylureas: results of randomized controlled trials and observational studies. Diabetes & Metabolism. 2018; 44: 386–392.
 
[16]  Tammineni ER, Kraeva N, Figueroa L, Manno C, Ibarra CA, Klip A, Riazi S, Rios E, Intracellular calcium leak lowers glucose storage in human muscle, promoting hyperglycemia and diabetes. Elife. 2020; 9: e53999.
 
[17]  Campbell JE, Newgard CB. Mechanisms controlling pancreatic islet cell function in insulin secretion, Nature Reviews Molecular Cell Biology. 2021; 22: 142–158.
 
[18]  Solverson P, Anthocyanin bioactivity in obesity and diabetes: The essential role of glucose transporters in the gut and periphery. Cells. 2020; 9:2515.
 
[19]  Bhatia KS, Roy A, Bhardavaj N, Anti-Hyperglycemic Property of Medicinal Plants. In: Medicinal Plants. Apple Academic Press. 2022. 147–193.
 
[20]  Niang L, Mahamat SA, Ayessou NC, Cisse M, Diop CM, Antioxidant Activity of Hydro-Acetonic, Hydro-Methanolic and Aqueous Leaf and Bark Extracts of Sclerocaria birrea (A.Rich.) Hochst. Food and Nutrition Sciences. 2021; 12: 429–438.
 
[21]  Andreadi A, Bellia A, Di Daniele N, Meloni M, Lauro R, Della Morte D, Lauro D, The molecular link between oxidative stress, insulin resistance, and type 2 diabetes: A target for newtherapies against cardiovascular diseases. Current Opinion in Pharmacology. 2022; 62: 85–96.